APA aipamena

Steidl, E., Filipski, K., Zeiner, P. S., Wagner, M., Fokas, E., Forster, M., . . . Bähr, O. (2021). A 25-year retrospective, single center analysis of 343 WHO grade II/III glioma patients: Implications for grading and temozolomide therapy. J Cancer Res Clin Oncol.

Chicago Style aipamena

Steidl, Eike, et al. "A 25-year Retrospective, Single Center Analysis of 343 WHO Grade II/III Glioma Patients: Implications for Grading and Temozolomide Therapy." J Cancer Res Clin Oncol 2021.

MLA aipamena

Steidl, Eike, et al. "A 25-year Retrospective, Single Center Analysis of 343 WHO Grade II/III Glioma Patients: Implications for Grading and Temozolomide Therapy." J Cancer Res Clin Oncol 2021.